Dicerna Pharmaceuticals Inc
0.00 (0.00%)


Draw Mode:

Volume 0
Bid Price 42.07
Ask Price 38.22
News -
Company Name Stock Ticker Symbol Market Type
Dicerna Pharmaceuticals Inc DRNA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 38.22 20:00:00
Open Price Low Price High Price Close Price Prev Close
38.22 38.22
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 38.22 USD

Dicerna Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.98B 77.91M 74.68M $ 146.23M $ -42.14M - -25.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -9.62M 0.20%

more financials information »

Dicerna Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No DRNA Message Board. Create One! See More Posts on DRNA Message Board See More Message Board Posts

Historical DRNA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Dicerna Pharmaceuticals Description

Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, cardiovascular diseases, cancers, and other liver problems. The company uses its ribonucleic acid interference technology platform to develop its products. In addition, Dicerna's proprietary GalXC technology focuses on silencing disease-causing genes. The product candidates are nedosiran (for primary hyperoxaluria), belcesiran (for genetic liver disease), DCR-PCSK9 (for cardiovascular disease), and RG6346 (for hepatitis B virus) among others. Dicerna generates revenue by forming collaborative relationships with pharmaceutical companies such as Eli Lilly, Roche, Novo Nordisk, and others.